VBI Vaccines
VBIV
#10367
Rank
A$3.09 M
Marketcap
$0.11
Share price
0.00%
Change (1 day)
-89.38%
Change (1 year)

Earnings for VBI Vaccines (VBIV)

Earnings in 2024 (TTM): -A$0.13 Billion

According to VBI Vaccines 's latest financial reports the company's current earnings are A$9.41 Million. In 2023 the company made an earning of -A$0.16 Billion, an increase over its 2022 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for VBI Vaccines from 1998 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.13 Billion-17.48%
2023 -A$0.16 Billion-18.06%
2022 -A$0.19 Billion62.43%
2021 -A$0.12 Billion50.88%
2020 -A$76.47 Million-15.66%
2019 -A$90.67 Million-13.82%
2018 -A$0.11 Billion61.32%
2017 -A$65.22 Million57.8%
2016 -A$41.33 Million-67.39%
2015 -A$0.13 Billion1527.36%
2014 -A$7.79 Million36.21%
2013 -A$5.72 Million-63.91%
2012 -A$15.85 Million-59.19%
2011 -A$38.83 Million227.23%
2010 -A$11.87 Million1741.53%
2009 -A$0.65 Million14.52%
2008 -A$0.57 Million-42.93%
2007 -A$0.99 Million21.8%
2006 -A$0.81 Million172.39%
2005 -A$0.3 Million115.38%
2004 -A$0.14 Million-42.27%
2003 -A$0.24 Million109.27%
2002 -A$0.12 Million17.89%
2001 -A$0.1 Million-369.64%
2000 A$0.03 M-69.24%
1999 A$0.11 M12.77%
1998 A$0.1 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$30.04 Million-78.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.2 Billion 45.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$74.12 Million-46.00%๐Ÿ‡บ๐Ÿ‡ธ USA